89bio, Inc. - Common stock, par value $0.001 per share (ETNB)
CUSIP: 282559103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 148,275,293
- Total 13F shares
- 90,017
- Share change
- -154,509,967
- Total reported value
- $1,107,252
- Price per share
- $13.56
- Number of holders
- 2
- Value change
- -$2,271,217,995
- Number of sells
- 192
Quarterly Holders Quick Answers
What is CUSIP 282559103?
CUSIP 282559103 identifies ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q3 2025
Recent filing periods for CUSIP 282559103:
Top shareholders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
|
Company · Director, 10%+ Owner |
13%
|
19,889,683
|
$292,378,340 | — | 30 Sep 2025 | |
| Pentwater Capital Management LP |
13F
|
Company |
7.9%
|
11,750,000
|
$172,725,000 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7%
|
10,316,393
|
$151,650,978 | — | 30 Sep 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
6.3%
|
9,356,171
|
$137,535,714 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.1%
|
9,097,587
|
$133,734,529 | — | 30 Sep 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
13F
|
Company |
5.6%
|
8,280,000
|
$121,716,000 | -$93,071,712 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5.6%
from 13D/G
|
8,053,459
|
$118,385,847 | — | 30 Sep 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.3%
|
6,387,790
|
$93,900,513 | — | 30 Sep 2025 | |
| GLAZER CAPITAL, LLC |
13F
|
Company |
3.8%
|
5,636,905
|
$82,863,000 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
3.6%
|
5,378,185
|
$79,060,933 | -$226,534,240 | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
5,286,308
|
$77,708,728 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.4%
|
3,499,625
|
$51,444,487 | — | 30 Sep 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.2%
|
3,291,369
|
$48,383,124 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
3,092,340
|
$45,463,604 | — | 30 Sep 2025 | |
| SYQUANT CAPITAL SAS |
13F
|
Company |
1.7%
|
2,593,694
|
$38,127,000 | — | 30 Sep 2025 | |
| KRYGER CAPITAL Ltd |
13F
|
Company |
1.6%
|
2,350,000
|
$34,545,000 | — | 30 Sep 2025 | |
| TIG Advisors, LLC |
13F
|
Company |
1.5%
|
2,186,648
|
$32,143,726 | — | 30 Sep 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
1.5%
|
2,172,000
|
$31,928,400 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.4%
|
2,113,153
|
$31,063,349 | — | 30 Sep 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
3.6%
|
4,333,885
|
$29,903,806 | $0 | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,616,785
|
$23,766,740 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
1,606,783
|
$23,619,710 | — | 30 Sep 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.99%
|
1,473,136
|
$21,655,099 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.98%
|
1,459,055
|
$21,448,109 | — | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,829,436
|
$21,093,397 | — | 25 Jan 2022 | |
| Weiss Asset Management LP |
13F
|
Company |
0.94%
|
1,400,000
|
$20,580,000 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
1,125,784
|
$16,549,026 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.68%
|
1,003,074
|
$14,745,188 | — | 30 Sep 2025 | |
| LMR Partners LLP |
13F
|
Company |
0.67%
|
1,000,000
|
$14,700,000 | — | 30 Sep 2025 | |
| RTW INVESTMENTS, LP |
13D/G
|
— |
1.3%
|
1,967,527
|
$13,575,936 | $0 | 31 Mar 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.56%
|
833,000
|
$12,245,100 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
820,620
|
$12,063,115 | — | 30 Sep 2025 | |
| Newtyn Management, LLC |
13F
|
Company |
0.54%
|
800,000
|
$11,760,000 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
725,823
|
$10,669,598 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.45%
|
666,842
|
$9,802,578 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.44%
|
651,873
|
$9,582,533 | — | 30 Sep 2025 | |
| CREDIT INDUSTRIEL ET COMMERCIAL |
13F
|
Individual |
0.4%
|
600,000
|
$8,820,000 | — | 30 Sep 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.39%
|
575,100
|
$8,453,970 | — | 30 Sep 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.36%
|
535,147
|
$7,866,661 | — | 30 Sep 2025 | |
| ALPINE ASSOCIATES MANAGEMENT INC. |
13F
|
Company |
0.36%
|
529,800
|
$7,788,060 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.36%
|
527,069
|
$7,747,916 | — | 30 Sep 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.35%
|
512,051
|
$7,527,150 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.34%
|
510,500
|
$7,504,350 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
444,767
|
$6,538,076 | — | 30 Sep 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.29%
|
434,025
|
$6,380,168 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.29%
|
428,720
|
$6,302,185 | — | 30 Sep 2025 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
0.28%
|
417,850
|
$6,142,395 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.28%
|
417,756
|
$6,141,013 | — | 30 Sep 2025 | |
| CSS LLC/IL |
13F
|
Company |
0.28%
|
409,571
|
$6,020,693 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.27%
|
400,154
|
$5,882,264 | — | 30 Sep 2025 |
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q4 2025
As of 31 Dec 2025,
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,017 shares.
The largest 2 holders included
DekaBank Deutsche Girozentrale and IFP Advisors, Inc.
This page lists
2
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
197
Q4 2025 holders
2
Holder diff
-195
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.